Andere talen Immunocore Holdings plc

Aandelen

IMCR

US45258D1054

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
58,46 ^USD	+0,79%		+4,99%	-14,43%

21/03	Immunocore Holdings dient een registratie in voor gemengde effecten	MT
14/03	Transcript : Immunocore Holdings plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:30 AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Immunocore announces upcoming presentation and posters at ASCO 2024	24/04
Immunocore to present at upcoming investor conferences	04/04
Immunocore Holdings Files Mixed-Securities Shelf Registration	21/03
Immunocore presented two posters at CROI 2024	05/03
Immunocore to present at upcoming investor conferences	01/03
Immunocore Holdings' Q4 Net Loss Narrows, Revenue Rises	28/02
Earnings Flash (IMCR) IMMUNOCORE HOLDINGS LIMITED Reports Q4 Revenue $70.2M, vs. Street Est of $68.5M	28/02
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update	28/02
Immunocore Holdings plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Immunocore Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Immunocore Collaborates With Bristol Myers Squibb in Advanced Cutaneous Melanoma Trial	22/02
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial	22/02
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024	21/02
Immunocore Prices Upsized $350 Million Convertible Notes Offering	31/01
Immunocore Prices Upsized Convertible Senior Notes Offering	31/01
Immunocore Prices Upsized Convertible Senior Notes Offering	31/01
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	30/01
Immunocore Plans $300 Million Convertible Senior Notes Offering ; Shares Fall After-Hours	29/01
Immunocore Holdings plc Provides Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Full Year 2023	29/01
Immunocore Announces Proposed Convertible Senior Notes Offering	29/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Immunocore Holdings plc

Aandelen

IMCR

US45258D1054

Andere talen

Filters